CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 101 enrolled
Drug / intervention
Rocuronium +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02838134
NCT02838134Phase 4Completed

The Effectiveness of Deep Versus Moderate Muscle Relaxation During Laparoscopic Donor Nephrectomy in Enhancing Postoperative Recovery

Radboud University Medical Center·interventional·Posted Jul 20, 2016·Updated Sep 19, 2019

In Brief

A Phase 4 clinical trial evaluating Rocuronium and No additional Rocuronium for Neuromuscular Block and 3 related conditions. Completed, enrolled 101 participants across 2 sites.

Detailed Summary

Postoperative recovery after live donor nephrectomy (LDN) is largely determined by the consequences of postoperative pain and analgesia consumptions. The investigators' goal is to establish the relationship between the use of deep neuromuscular blockade (NMB) during laparoscopic donor nephrectomy (LDN) and the early quality of recovery. Therefore, the investigators designed a trial in which patients scheduled for living donor nephrectomy are randomized into a group with deep NMB or moderate NMB. The primary outcome measurement will be the Quality of Recovery-40 questionnaire (overall score) at 48 hours after extubation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedJul 20, 2016
Enrollment StartNov 1, 2016
Primary CompletionNov 2, 2017
Study CompletionDec 2, 2017
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 10.0 years ago

Interventions

Rocuroniumother

A bolus of 0.7 mg/kg rocuronium is administered just after tracheal intubation and then an infusion of rocuronium (0.3 to 0.4 mg/kg) is started when post-tetanic count (PTC) is more than 0 and titrated towards PTC 1-2.

No additional Rocuroniumother

No additional rocuronium is administered after tracheal intubation.